Allergic contact dermatitis from topical doxepin: Food and Drug Administration's postmarketing surveillance experience
| Autor: | Claudia B. Karwoski, Lois La Grenade, Renan A. Bonnel, Julie Beitz |
|---|---|
| Rok vydání: | 2003 |
| Předmět: |
Adult
Male Allergy medicine.medical_specialty Administration Topical Postmarketing surveillance Dermatology Food and drug administration Pharmacovigilance Product Surveillance Postmarketing Medicine Topical doxepin Humans Allergic contact dermatitis business.industry digestive oral and skin physiology Antipruritics Middle Aged Doxepin medicine.disease Dermatitis Allergic Contact Female business Contact dermatitis medicine.drug |
| Zdroj: | Journal of the American Academy of Dermatology. 48(2) |
| ISSN: | 0190-9622 |
| Popis: | A total of 26 postmarketing cases of allergic contact dermatitis to doxepin 5% cream were reported to the Food and Drug Administration. Our findings suggest that allergic contact dermatitis was more common when treatment duration exceeded the recommended 8 days. Allergic contact dermatitis to doxepin cream should be considered in patients whose condition fails to improve or worsens with doxepin use. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect